Harbin Pharmaceutical Group Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 10,788.456 million compared to CNY 11,824.561 million a year ago. Operating loss was CNY 942.108 million compared to operating Income of CNY 277.742 million a year ago. Net loss was CNY 1,077.699 million compared to net income of CNY 55.812 million a year ago. Basic loss per share from continuing operations was CNY 0.43 compared to basic earnings per share from continuing operations of CNY 0.02 a year ago.